Magda Gunn has obtained her master’s degree in chemistry from Adam Mickiewicz University in Poznan, Poland in 2001. In 2007 she obtained her Ph.D. in chemistry from North Carolina State University in Raleigh, North Carolina, USA.
Her career continued at a biotech company SomaLogic in Boulder Colorado, USA. There she was involved in aptamer technology and its applications for diagnostic tools development as well as for therapeutic and target validation reagents. She led one of the key therapeutic pilot projects.
In March 2013 Magda Gunn has joined IMI as a scientific project manager. One of her main tasks is development of a methodology for measuring achievements and Key Performance Indicators of this public private partnership. She is also responsible for coordination of the interim reviews of on-going projects as well as scientific management some of the consortia.